Review article

https://doi.org/10.26800/LV-144-supl1-23

Multisystem inflammatory syndrome in children (MIS-C)

Lorna Stemberger Marić ; Klinika za infektivne bolesti „dr.Fran Mihaljević“, Zagreb, Medicinski fakultet Sveučilišta u Zagrebu
Hrvoje Kniewald ; Klinika za pedijatriju KBC „Sestre Milosrdnice“, Zagreb

Abstract

Multisystemic inflammatory syndrome in children associated with COVID-19 is a relatively new clinical syndrome similar to Kawasaki disease that occurs about 2–6 weeks after SARS-CoV-2 infection. The disease is characterized by fever and involvement of several organ systems (skin/mucous membranes, gastrointestinal, cardiovascular...) associated with elevated inflammatory parameters. There is no specific diagnostic test to confirm this disease, it is a diagnosis of exclusion, based on specific diagnostic criteria. The basis of treatment is the use of intravenous immunoglobulins and corticosteroids with symptomatic and supportive measures. The disease is characterized by tendency to cause cardiac complications, which is why it is important to systematically monitor these patients even after acute illness.

Keywords

MULTISISTEMSKI UPALNI SINDROM U DJECE POVEZAN S COVID-19, DIJAGNOZA, LIJEČENJE

Hrčak ID:

275750

URI

https://hrcak.srce.hr/275750

Publication date:

24.4.2022.

Article data in other languages: croatian

Visits: 2.678 *